Literature DB >> 19559755

Epigenetic mechanisms in schizophrenia.

Tania L Roth1, Farah D Lubin, Monsheel Sodhi, Joel E Kleinman.   

Abstract

Epidemiological research suggests that both an individual's genes and the environment underlie the pathophysiology of schizophrenia. Molecular mechanisms mediating the interplay between genes and the environment are likely to have a significant role in the onset of the disorder. Recent work indicates that epigenetic mechanisms, or the chemical markings of the DNA and the surrounding histone proteins, remain labile through the lifespan and can be altered by environmental factors. Thus, epigenetic mechanisms are an attractive molecular hypothesis for environmental contributions to schizophrenia. In this review, we first present an overview of schizophrenia and discuss the role of nature versus nurture in its pathology, where 'nature' is considered to be inherited or genetic vulnerability to schizophrenia, and 'nurture' is proposed to exert its effects through epigenetic mechanisms. Second, we define DNA methylation and discuss the evidence for its role in schizophrenia. Third, we define posttranslational histone modifications and discuss their place in schizophrenia. This research is likely to lead to the development of epigenetic therapy, which holds the promise of alleviating cognitive deficits associated with schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19559755      PMCID: PMC2779706          DOI: 10.1016/j.bbagen.2009.06.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  167 in total

1.  Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk.

Authors:  K K Nicodemus; S Marenco; A J Batten; R Vakkalanka; M F Egan; R E Straub; D R Weinberger
Journal:  Mol Psychiatry       Date:  2008-01-15       Impact factor: 15.992

Review 2.  Epigenetic therapeutic strategies for the treatment of neuropsychiatric disorders: ready for prime time?

Authors:  Stephen I Deutsch; Richard B Rosse; John Mastropaolo; Katrice D Long; Brooke L Gaskins
Journal:  Clin Neuropharmacol       Date:  2008 Mar-Apr       Impact factor: 1.592

3.  Polymorphic imprinting of the serotonin-2A (5-HT2A) receptor gene in human adult brain.

Authors:  R Bunzel; I Blümcke; S Cichon; S Normann; J Schramm; P Propping; M M Nöthen
Journal:  Brain Res Mol Brain Res       Date:  1998-08-15

Review 4.  Epidemiology and seasonal affective disorder.

Authors:  M R Eastwood; A M Peter
Journal:  Psychol Med       Date:  1988-11       Impact factor: 7.723

Review 5.  The human reelin gene: transcription factors (+), repressors (-) and the methylation switch (+/-) in schizophrenia.

Authors:  Dennis R Grayson; Ying Chen; Erminio Costa; Erbo Dong; Alessandro Guidotti; Marija Kundakovic; Rajiv P Sharma
Journal:  Pharmacol Ther       Date:  2006-03-30       Impact factor: 12.310

Review 6.  GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia.

Authors:  Guillermo Gonzalez-Burgos; David A Lewis
Journal:  Schizophr Bull       Date:  2008-06-26       Impact factor: 9.306

Review 7.  Molecular biology of 5-HT receptors.

Authors:  Jason Hannon; Daniel Hoyer
Journal:  Behav Brain Res       Date:  2008-03-25       Impact factor: 3.332

8.  Socio-economic mobility among patients with schizophrenia or major affective disorder. A 17-year retrospective follow-up.

Authors:  S Aro; H Aro; I Keskimäki
Journal:  Br J Psychiatry       Date:  1995-06       Impact factor: 9.319

9.  Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.

Authors:  R A Glennon; M Titeler; J D McKenney
Journal:  Life Sci       Date:  1984-12-17       Impact factor: 5.037

10.  The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes.

Authors:  Marija Kundakovic; Ying Chen; Alessandro Guidotti; Dennis R Grayson
Journal:  Mol Pharmacol       Date:  2008-11-24       Impact factor: 4.436

View more
  58 in total

1.  Chronic administration of the neurotrophic agent cerebrolysin ameliorates the behavioral and morphological changes induced by neonatal ventral hippocampus lesion in a rat model of schizophrenia.

Authors:  Rubén Antonio Vázquez-Roque; Brenda Ramos; Carolina Tecuatl; Ismael Juárez; Anthony Adame; Fidel de la Cruz; Sergio Zamudio; Raúl Mena; Edward Rockenstein; Eliezer Masliah; Gonzalo Flores
Journal:  J Neurosci Res       Date:  2011-09-19       Impact factor: 4.164

2.  Effects of premature birth on the risk for alcoholism appear to be greater in males than females.

Authors:  Ann M Manzardo; Wendy V Madarasz; Elizabeth C Penick; Joachim Knop; Erik Lykke Mortensen; Holger J Sorensen; Jonathan D Mahnken; Ulrik Becker; Elizabeth J Nickel; William F Gabrielli
Journal:  J Stud Alcohol Drugs       Date:  2011-05       Impact factor: 2.582

3.  Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice.

Authors:  Francesco Matrisciano; Patricia Tueting; Stefania Maccari; Ferdinando Nicoletti; Alessandro Guidotti
Journal:  Neuropsychopharmacology       Date:  2011-11-16       Impact factor: 7.853

Review 4.  Epigenetic GABAergic targets in schizophrenia and bipolar disorder.

Authors:  A Guidotti; J Auta; Y Chen; J M Davis; E Dong; D P Gavin; D R Grayson; F Matrisciano; G Pinna; R Satta; R P Sharma; L Tremolizzo; P Tueting
Journal:  Neuropharmacology       Date:  2010-11-11       Impact factor: 5.250

5.  Gene expression in superior temporal cortex of schizophrenia patients.

Authors:  C Sellmann; L Villarín Pildaín; A Schmitt; F Leonardi-Essmann; P F Durrenberger; R Spanagel; T Arzberger; H Kretzschmar; M Zink; O Gruber; M Herrera-Marschitz; R Reynolds; P Falkai; P J Gebicke-Haerter; F Matthäus
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-11-28       Impact factor: 5.270

6.  Immersion in altered experience: An investigation of the relationship between absorption and psychopathology.

Authors:  Cherise Rosen; Nev Jones; Kayla A Chase; Jennifer K Melbourne; Linda S Grossman; Rajiv P Sharma
Journal:  Conscious Cogn       Date:  2017-02-20

Review 7.  BDNF-TrkB signaling and neuroprotection in schizophrenia.

Authors:  Chirayu D Pandya; Ammar Kutiyanawalla; Anilkumar Pillai
Journal:  Asian J Psychiatr       Date:  2012-11-03

8.  Nicotine restores Wt-like levels of reelin and GAD67 gene expression in brain of heterozygous reeler mice.

Authors:  Emilia Romano; Andrea Fuso; Giovanni Laviola
Journal:  Neurotox Res       Date:  2013-02-06       Impact factor: 3.911

9.  Modulation of neuronal plasticity following chronic concomitant administration of the novel antipsychotic lurasidone with the mood stabilizer valproic acid.

Authors:  F Calabrese; A Luoni; G Guidotti; G Racagni; F Fumagalli; M A Riva
Journal:  Psychopharmacology (Berl)       Date:  2012-10-24       Impact factor: 4.530

10.  Altered Signaling in CB1R-5-HT2AR Heteromers in Olfactory Neuroepithelium Cells of Schizophrenia Patients is Modulated by Cannabis Use.

Authors:  Daniel Guinart; Estefanía Moreno; Liliana Galindo; Aida Cuenca-Royo; Marta Barrera-Conde; Ezequiel J Pérez; Cristina Fernández-Avilés; Christoph U Correll; Enric I Canela; Vicent Casadó; Arnau Cordomi; Leonardo Pardo; Rafael de la Torre; Víctor Pérez; Patricia Robledo
Journal:  Schizophr Bull       Date:  2020-12-01       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.